Crossmark Global Holdings’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,336
| Closed | -$232K | – | 1342 |
|
|
2023
Q4 | $232K | Sell |
5,336
-729
| -12% | -$31.7K | ﹤0.01% | 1193 |
|
|
2023
Q3 | $234K | Sell |
6,065
-214
| -3% | -$8.26K | 0.01% | 1133 |
|
|
2023
Q2 | $285K | Sell |
6,279
-456
| -7% | -$20.7K | 0.01% | 1093 |
|
|
2023
Q1 | $387K | Buy |
6,735
+10
| +0.1% | +$575 | 0.01% | 930 |
|
|
2022
Q4 | $377K | Sell |
6,725
-427
| -6% | -$23.9K | 0.01% | 920 |
|
|
2022
Q3 | $303K | Sell |
7,152
-100
| -1% | -$4.24K | 0.01% | 989 |
|
|
2022
Q2 | $392K | Sell |
7,252
-250
| -3% | -$13.5K | 0.01% | 921 |
|
|
2022
Q1 | $482K | Buy |
7,502
+190
| +3% | +$12.2K | 0.01% | 913 |
|
|
2021
Q4 | $490K | Buy |
7,312
+780
| +12% | +$52.3K | 0.01% | 903 |
|
|
2021
Q3 | $447K | Buy |
6,532
+20
| +0.3% | +$1.37K | 0.01% | 977 |
|
|
2021
Q2 | $444K | Buy |
6,512
+330
| +5% | +$22.5K | 0.01% | 989 |
|
|
2021
Q1 | $427K | Hold |
6,182
| – | – | 0.01% | 983 |
|
|
2020
Q4 | $401K | Sell |
6,182
-180
| -3% | -$11.7K | 0.01% | 945 |
|
|
2020
Q3 | $300K | Sell |
6,362
-20
| -0.3% | -$943 | 0.01% | 1029 |
|
|
2020
Q2 | $300K | Sell |
6,382
-48
| -0.7% | -$2.26K | 0.01% | 1012 |
|
|
2020
Q1 | $287K | Sell |
6,430
-30
| -0.5% | -$1.34K | 0.01% | 875 |
|
|
2019
Q4 | $376K | Sell |
6,460
-2,270
| -26% | -$132K | 0.01% | 982 |
|
|
2019
Q3 | $524K | Sell |
8,730
-460
| -5% | -$27.6K | 0.02% | 770 |
|
|
2019
Q2 | $513K | Sell |
9,190
-210
| -2% | -$11.7K | 0.01% | 796 |
|
|
2019
Q1 | $524K | Buy |
9,400
+60
| +0.6% | +$3.35K | 0.01% | 789 |
|
|
2018
Q4 | $421K | Buy |
9,340
+1,990
| +27% | +$89.7K | 0.01% | 852 |
|
|
2018
Q3 | $484K | Buy |
7,350
+70
| +1% | +$4.61K | 0.01% | 975 |
|
|
2018
Q2 | $469K | Sell |
7,280
-2,630
| -27% | -$169K | 0.01% | 992 |
|
|
2018
Q1 | $548K | Sell |
9,910
-2,520
| -20% | -$139K | 0.01% | 858 |
|
|
2017
Q4 | $595K | Buy |
12,430
+160
| +1% | +$7.66K | 0.01% | 866 |
|
|
2017
Q3 | $619K | Buy |
+12,270
| New | +$619K | 0.02% | 828 |
|
|
2016
Q3 | $619K | Buy |
+24,540
| New | +$619K | 0.02% | 828 |
|